Global Vaccines for the Elderly Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Vaccines for the Elderly market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Vaccines for the Elderly industry chain, the market status of Hospital (Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine), Clinic (Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccines for the Elderly.
Regionally, the report analyzes the Vaccines for the Elderly markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccines for the Elderly market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccines for the Elderly market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccines for the Elderly industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccines for the Elderly market.
Regional Analysis: The report involves examining the Vaccines for the Elderly market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccines for the Elderly market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccines for the Elderly:
Company Analysis: Report covers individual Vaccines for the Elderly manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccines for the Elderly This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Vaccines for the Elderly. It assesses the current state, advancements, and potential future developments in Vaccines for the Elderly areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccines for the Elderly market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccines for the Elderly market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Vaccines for the Elderly product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccines for the Elderly, with price, sales, revenue and global market share of Vaccines for the Elderly from 2019 to 2024.
Chapter 3, the Vaccines for the Elderly competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines for the Elderly breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Vaccines for the Elderly market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccines for the Elderly.
Chapter 14 and 15, to describe Vaccines for the Elderly sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Vaccines for the Elderly industry chain, the market status of Hospital (Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine), Clinic (Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccines for the Elderly.
Regionally, the report analyzes the Vaccines for the Elderly markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccines for the Elderly market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccines for the Elderly market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccines for the Elderly industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccines for the Elderly market.
Regional Analysis: The report involves examining the Vaccines for the Elderly market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccines for the Elderly market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccines for the Elderly:
Company Analysis: Report covers individual Vaccines for the Elderly manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccines for the Elderly This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Vaccines for the Elderly. It assesses the current state, advancements, and potential future developments in Vaccines for the Elderly areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccines for the Elderly market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccines for the Elderly market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Flu Vaccine
- Respiratory Syncytial Virus (RSV) Vaccine
- Recombinant Herpes Zoster Vaccine
- 23-Valent Pneumococcal Polysaccharide Vaccine
- Others
- Hospital
- Clinic
- Public Health Agency
- Others
- Pfizer
- GSK
- Merck
- CSL
- Sanofi
- AstraZeneca
- Hualan Bio
- Sinovac
- Kangtai Bio
- CDIBP
- Walvax
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Vaccines for the Elderly product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccines for the Elderly, with price, sales, revenue and global market share of Vaccines for the Elderly from 2019 to 2024.
Chapter 3, the Vaccines for the Elderly competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines for the Elderly breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Vaccines for the Elderly market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccines for the Elderly.
Chapter 14 and 15, to describe Vaccines for the Elderly sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Vaccines for the Elderly
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vaccines for the Elderly Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Flu Vaccine
1.3.3 Respiratory Syncytial Virus (RSV) Vaccine
1.3.4 Recombinant Herpes Zoster Vaccine
1.3.5 23-Valent Pneumococcal Polysaccharide Vaccine
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Vaccines for the Elderly Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Public Health Agency
1.4.5 Others
1.5 Global Vaccines for the Elderly Market Size & Forecast
1.5.1 Global Vaccines for the Elderly Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Vaccines for the Elderly Sales Quantity (2019-2030)
1.5.3 Global Vaccines for the Elderly Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Vaccines for the Elderly Product and Services
2.1.4 Pfizer Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Vaccines for the Elderly Product and Services
2.2.4 GSK Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Vaccines for the Elderly Product and Services
2.3.4 Merck Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Vaccines for the Elderly Product and Services
2.4.4 CSL Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CSL Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Vaccines for the Elderly Product and Services
2.5.4 Sanofi Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Vaccines for the Elderly Product and Services
2.6.4 AstraZeneca Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Vaccines for the Elderly Product and Services
2.7.4 Hualan Bio Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Bio Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Vaccines for the Elderly Product and Services
2.8.4 Sinovac Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sinovac Recent Developments/Updates
2.9 Kangtai Bio
2.9.1 Kangtai Bio Details
2.9.2 Kangtai Bio Major Business
2.9.3 Kangtai Bio Vaccines for the Elderly Product and Services
2.9.4 Kangtai Bio Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kangtai Bio Recent Developments/Updates
2.10 CDIBP
2.10.1 CDIBP Details
2.10.2 CDIBP Major Business
2.10.3 CDIBP Vaccines for the Elderly Product and Services
2.10.4 CDIBP Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CDIBP Recent Developments/Updates
2.11 Walvax
2.11.1 Walvax Details
2.11.2 Walvax Major Business
2.11.3 Walvax Vaccines for the Elderly Product and Services
2.11.4 Walvax Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Walvax Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VACCINES FOR THE ELDERLY BY MANUFACTURER
3.1 Global Vaccines for the Elderly Sales Quantity by Manufacturer (2019-2024)
3.2 Global Vaccines for the Elderly Revenue by Manufacturer (2019-2024)
3.3 Global Vaccines for the Elderly Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Vaccines for the Elderly by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Vaccines for the Elderly Manufacturer Market Share in 2023
3.4.2 Top 6 Vaccines for the Elderly Manufacturer Market Share in 2023
3.5 Vaccines for the Elderly Market: Overall Company Footprint Analysis
3.5.1 Vaccines for the Elderly Market: Region Footprint
3.5.2 Vaccines for the Elderly Market: Company Product Type Footprint
3.5.3 Vaccines for the Elderly Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Vaccines for the Elderly Market Size by Region
4.1.1 Global Vaccines for the Elderly Sales Quantity by Region (2019-2030)
4.1.2 Global Vaccines for the Elderly Consumption Value by Region (2019-2030)
4.1.3 Global Vaccines for the Elderly Average Price by Region (2019-2030)
4.2 North America Vaccines for the Elderly Consumption Value (2019-2030)
4.3 Europe Vaccines for the Elderly Consumption Value (2019-2030)
4.4 Asia-Pacific Vaccines for the Elderly Consumption Value (2019-2030)
4.5 South America Vaccines for the Elderly Consumption Value (2019-2030)
4.6 Middle East and Africa Vaccines for the Elderly Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Vaccines for the Elderly Sales Quantity by Type (2019-2030)
5.2 Global Vaccines for the Elderly Consumption Value by Type (2019-2030)
5.3 Global Vaccines for the Elderly Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Vaccines for the Elderly Sales Quantity by Application (2019-2030)
6.2 Global Vaccines for the Elderly Consumption Value by Application (2019-2030)
6.3 Global Vaccines for the Elderly Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Vaccines for the Elderly Sales Quantity by Type (2019-2030)
7.2 North America Vaccines for the Elderly Sales Quantity by Application (2019-2030)
7.3 North America Vaccines for the Elderly Market Size by Country
7.3.1 North America Vaccines for the Elderly Sales Quantity by Country (2019-2030)
7.3.2 North America Vaccines for the Elderly Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Vaccines for the Elderly Sales Quantity by Type (2019-2030)
8.2 Europe Vaccines for the Elderly Sales Quantity by Application (2019-2030)
8.3 Europe Vaccines for the Elderly Market Size by Country
8.3.1 Europe Vaccines for the Elderly Sales Quantity by Country (2019-2030)
8.3.2 Europe Vaccines for the Elderly Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Vaccines for the Elderly Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Vaccines for the Elderly Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Vaccines for the Elderly Market Size by Region
9.3.1 Asia-Pacific Vaccines for the Elderly Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Vaccines for the Elderly Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Vaccines for the Elderly Sales Quantity by Type (2019-2030)
10.2 South America Vaccines for the Elderly Sales Quantity by Application (2019-2030)
10.3 South America Vaccines for the Elderly Market Size by Country
10.3.1 South America Vaccines for the Elderly Sales Quantity by Country (2019-2030)
10.3.2 South America Vaccines for the Elderly Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Vaccines for the Elderly Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Vaccines for the Elderly Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Vaccines for the Elderly Market Size by Country
11.3.1 Middle East & Africa Vaccines for the Elderly Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Vaccines for the Elderly Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Vaccines for the Elderly Market Drivers
12.2 Vaccines for the Elderly Market Restraints
12.3 Vaccines for the Elderly Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Vaccines for the Elderly and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vaccines for the Elderly
13.3 Vaccines for the Elderly Production Process
13.4 Vaccines for the Elderly Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vaccines for the Elderly Typical Distributors
14.3 Vaccines for the Elderly Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Vaccines for the Elderly
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vaccines for the Elderly Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Flu Vaccine
1.3.3 Respiratory Syncytial Virus (RSV) Vaccine
1.3.4 Recombinant Herpes Zoster Vaccine
1.3.5 23-Valent Pneumococcal Polysaccharide Vaccine
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Vaccines for the Elderly Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Public Health Agency
1.4.5 Others
1.5 Global Vaccines for the Elderly Market Size & Forecast
1.5.1 Global Vaccines for the Elderly Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Vaccines for the Elderly Sales Quantity (2019-2030)
1.5.3 Global Vaccines for the Elderly Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Vaccines for the Elderly Product and Services
2.1.4 Pfizer Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Vaccines for the Elderly Product and Services
2.2.4 GSK Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Vaccines for the Elderly Product and Services
2.3.4 Merck Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Vaccines for the Elderly Product and Services
2.4.4 CSL Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CSL Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Vaccines for the Elderly Product and Services
2.5.4 Sanofi Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Vaccines for the Elderly Product and Services
2.6.4 AstraZeneca Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Vaccines for the Elderly Product and Services
2.7.4 Hualan Bio Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Bio Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Vaccines for the Elderly Product and Services
2.8.4 Sinovac Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sinovac Recent Developments/Updates
2.9 Kangtai Bio
2.9.1 Kangtai Bio Details
2.9.2 Kangtai Bio Major Business
2.9.3 Kangtai Bio Vaccines for the Elderly Product and Services
2.9.4 Kangtai Bio Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kangtai Bio Recent Developments/Updates
2.10 CDIBP
2.10.1 CDIBP Details
2.10.2 CDIBP Major Business
2.10.3 CDIBP Vaccines for the Elderly Product and Services
2.10.4 CDIBP Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CDIBP Recent Developments/Updates
2.11 Walvax
2.11.1 Walvax Details
2.11.2 Walvax Major Business
2.11.3 Walvax Vaccines for the Elderly Product and Services
2.11.4 Walvax Vaccines for the Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Walvax Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VACCINES FOR THE ELDERLY BY MANUFACTURER
3.1 Global Vaccines for the Elderly Sales Quantity by Manufacturer (2019-2024)
3.2 Global Vaccines for the Elderly Revenue by Manufacturer (2019-2024)
3.3 Global Vaccines for the Elderly Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Vaccines for the Elderly by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Vaccines for the Elderly Manufacturer Market Share in 2023
3.4.2 Top 6 Vaccines for the Elderly Manufacturer Market Share in 2023
3.5 Vaccines for the Elderly Market: Overall Company Footprint Analysis
3.5.1 Vaccines for the Elderly Market: Region Footprint
3.5.2 Vaccines for the Elderly Market: Company Product Type Footprint
3.5.3 Vaccines for the Elderly Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Vaccines for the Elderly Market Size by Region
4.1.1 Global Vaccines for the Elderly Sales Quantity by Region (2019-2030)
4.1.2 Global Vaccines for the Elderly Consumption Value by Region (2019-2030)
4.1.3 Global Vaccines for the Elderly Average Price by Region (2019-2030)
4.2 North America Vaccines for the Elderly Consumption Value (2019-2030)
4.3 Europe Vaccines for the Elderly Consumption Value (2019-2030)
4.4 Asia-Pacific Vaccines for the Elderly Consumption Value (2019-2030)
4.5 South America Vaccines for the Elderly Consumption Value (2019-2030)
4.6 Middle East and Africa Vaccines for the Elderly Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Vaccines for the Elderly Sales Quantity by Type (2019-2030)
5.2 Global Vaccines for the Elderly Consumption Value by Type (2019-2030)
5.3 Global Vaccines for the Elderly Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Vaccines for the Elderly Sales Quantity by Application (2019-2030)
6.2 Global Vaccines for the Elderly Consumption Value by Application (2019-2030)
6.3 Global Vaccines for the Elderly Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Vaccines for the Elderly Sales Quantity by Type (2019-2030)
7.2 North America Vaccines for the Elderly Sales Quantity by Application (2019-2030)
7.3 North America Vaccines for the Elderly Market Size by Country
7.3.1 North America Vaccines for the Elderly Sales Quantity by Country (2019-2030)
7.3.2 North America Vaccines for the Elderly Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Vaccines for the Elderly Sales Quantity by Type (2019-2030)
8.2 Europe Vaccines for the Elderly Sales Quantity by Application (2019-2030)
8.3 Europe Vaccines for the Elderly Market Size by Country
8.3.1 Europe Vaccines for the Elderly Sales Quantity by Country (2019-2030)
8.3.2 Europe Vaccines for the Elderly Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Vaccines for the Elderly Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Vaccines for the Elderly Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Vaccines for the Elderly Market Size by Region
9.3.1 Asia-Pacific Vaccines for the Elderly Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Vaccines for the Elderly Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Vaccines for the Elderly Sales Quantity by Type (2019-2030)
10.2 South America Vaccines for the Elderly Sales Quantity by Application (2019-2030)
10.3 South America Vaccines for the Elderly Market Size by Country
10.3.1 South America Vaccines for the Elderly Sales Quantity by Country (2019-2030)
10.3.2 South America Vaccines for the Elderly Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Vaccines for the Elderly Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Vaccines for the Elderly Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Vaccines for the Elderly Market Size by Country
11.3.1 Middle East & Africa Vaccines for the Elderly Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Vaccines for the Elderly Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Vaccines for the Elderly Market Drivers
12.2 Vaccines for the Elderly Market Restraints
12.3 Vaccines for the Elderly Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Vaccines for the Elderly and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vaccines for the Elderly
13.3 Vaccines for the Elderly Production Process
13.4 Vaccines for the Elderly Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vaccines for the Elderly Typical Distributors
14.3 Vaccines for the Elderly Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Vaccines for the Elderly Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Vaccines for the Elderly Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Vaccines for the Elderly Product and Services
Table 6. Pfizer Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Vaccines for the Elderly Product and Services
Table 11. GSK Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Vaccines for the Elderly Product and Services
Table 16. Merck Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. CSL Basic Information, Manufacturing Base and Competitors
Table 19. CSL Major Business
Table 20. CSL Vaccines for the Elderly Product and Services
Table 21. CSL Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. CSL Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Vaccines for the Elderly Product and Services
Table 26. Sanofi Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sanofi Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Vaccines for the Elderly Product and Services
Table 31. AstraZeneca Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Bio Major Business
Table 35. Hualan Bio Vaccines for the Elderly Product and Services
Table 36. Hualan Bio Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Hualan Bio Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Vaccines for the Elderly Product and Services
Table 41. Sinovac Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sinovac Recent Developments/Updates
Table 43. Kangtai Bio Basic Information, Manufacturing Base and Competitors
Table 44. Kangtai Bio Major Business
Table 45. Kangtai Bio Vaccines for the Elderly Product and Services
Table 46. Kangtai Bio Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Kangtai Bio Recent Developments/Updates
Table 48. CDIBP Basic Information, Manufacturing Base and Competitors
Table 49. CDIBP Major Business
Table 50. CDIBP Vaccines for the Elderly Product and Services
Table 51. CDIBP Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CDIBP Recent Developments/Updates
Table 53. Walvax Basic Information, Manufacturing Base and Competitors
Table 54. Walvax Major Business
Table 55. Walvax Vaccines for the Elderly Product and Services
Table 56. Walvax Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Walvax Recent Developments/Updates
Table 58. Global Vaccines for the Elderly Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Vaccines for the Elderly Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Vaccines for the Elderly Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Vaccines for the Elderly, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Vaccines for the Elderly Production Site of Key Manufacturer
Table 63. Vaccines for the Elderly Market: Company Product Type Footprint
Table 64. Vaccines for the Elderly Market: Company Product Application Footprint
Table 65. Vaccines for the Elderly New Market Entrants and Barriers to Market Entry
Table 66. Vaccines for the Elderly Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Vaccines for the Elderly Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Vaccines for the Elderly Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Vaccines for the Elderly Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Vaccines for the Elderly Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Vaccines for the Elderly Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Vaccines for the Elderly Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Vaccines for the Elderly Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Vaccines for the Elderly Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Vaccines for the Elderly Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Vaccines for the Elderly Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Vaccines for the Elderly Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Vaccines for the Elderly Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Vaccines for the Elderly Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Vaccines for the Elderly Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Vaccines for the Elderly Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Vaccines for the Elderly Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Vaccines for the Elderly Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Vaccines for the Elderly Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Vaccines for the Elderly Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Vaccines for the Elderly Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Vaccines for the Elderly Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Vaccines for the Elderly Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Vaccines for the Elderly Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Vaccines for the Elderly Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Vaccines for the Elderly Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Vaccines for the Elderly Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Vaccines for the Elderly Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Vaccines for the Elderly Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Vaccines for the Elderly Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Vaccines for the Elderly Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Vaccines for the Elderly Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Vaccines for the Elderly Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Vaccines for the Elderly Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Vaccines for the Elderly Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Vaccines for the Elderly Raw Material
Table 126. Key Manufacturers of Vaccines for the Elderly Raw Materials
Table 127. Vaccines for the Elderly Typical Distributors
Table 128. Vaccines for the Elderly Typical Customers
Table 1. Global Vaccines for the Elderly Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Vaccines for the Elderly Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Vaccines for the Elderly Product and Services
Table 6. Pfizer Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Vaccines for the Elderly Product and Services
Table 11. GSK Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Vaccines for the Elderly Product and Services
Table 16. Merck Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. CSL Basic Information, Manufacturing Base and Competitors
Table 19. CSL Major Business
Table 20. CSL Vaccines for the Elderly Product and Services
Table 21. CSL Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. CSL Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Vaccines for the Elderly Product and Services
Table 26. Sanofi Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sanofi Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Vaccines for the Elderly Product and Services
Table 31. AstraZeneca Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Bio Major Business
Table 35. Hualan Bio Vaccines for the Elderly Product and Services
Table 36. Hualan Bio Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Hualan Bio Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Vaccines for the Elderly Product and Services
Table 41. Sinovac Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sinovac Recent Developments/Updates
Table 43. Kangtai Bio Basic Information, Manufacturing Base and Competitors
Table 44. Kangtai Bio Major Business
Table 45. Kangtai Bio Vaccines for the Elderly Product and Services
Table 46. Kangtai Bio Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Kangtai Bio Recent Developments/Updates
Table 48. CDIBP Basic Information, Manufacturing Base and Competitors
Table 49. CDIBP Major Business
Table 50. CDIBP Vaccines for the Elderly Product and Services
Table 51. CDIBP Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CDIBP Recent Developments/Updates
Table 53. Walvax Basic Information, Manufacturing Base and Competitors
Table 54. Walvax Major Business
Table 55. Walvax Vaccines for the Elderly Product and Services
Table 56. Walvax Vaccines for the Elderly Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Walvax Recent Developments/Updates
Table 58. Global Vaccines for the Elderly Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Vaccines for the Elderly Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Vaccines for the Elderly Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Vaccines for the Elderly, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Vaccines for the Elderly Production Site of Key Manufacturer
Table 63. Vaccines for the Elderly Market: Company Product Type Footprint
Table 64. Vaccines for the Elderly Market: Company Product Application Footprint
Table 65. Vaccines for the Elderly New Market Entrants and Barriers to Market Entry
Table 66. Vaccines for the Elderly Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Vaccines for the Elderly Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Vaccines for the Elderly Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Vaccines for the Elderly Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Vaccines for the Elderly Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Vaccines for the Elderly Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Vaccines for the Elderly Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Vaccines for the Elderly Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Vaccines for the Elderly Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Vaccines for the Elderly Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Vaccines for the Elderly Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Vaccines for the Elderly Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Vaccines for the Elderly Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Vaccines for the Elderly Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Vaccines for the Elderly Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Vaccines for the Elderly Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Vaccines for the Elderly Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Vaccines for the Elderly Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Vaccines for the Elderly Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Vaccines for the Elderly Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Vaccines for the Elderly Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Vaccines for the Elderly Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Vaccines for the Elderly Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Vaccines for the Elderly Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Vaccines for the Elderly Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Vaccines for the Elderly Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Vaccines for the Elderly Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Vaccines for the Elderly Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Vaccines for the Elderly Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Vaccines for the Elderly Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Vaccines for the Elderly Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Vaccines for the Elderly Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Vaccines for the Elderly Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Vaccines for the Elderly Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Vaccines for the Elderly Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Vaccines for the Elderly Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Vaccines for the Elderly Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Vaccines for the Elderly Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Vaccines for the Elderly Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Vaccines for the Elderly Raw Material
Table 126. Key Manufacturers of Vaccines for the Elderly Raw Materials
Table 127. Vaccines for the Elderly Typical Distributors
Table 128. Vaccines for the Elderly Typical Customers
LIST OF FIGURES
Figure 1. Vaccines for the Elderly Picture
Figure 2. Global Vaccines for the Elderly Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Vaccines for the Elderly Consumption Value Market Share by Type in 2023
Figure 4. Flu Vaccine Examples
Figure 5. Respiratory Syncytial Virus (RSV) Vaccine Examples
Figure 6. Recombinant Herpes Zoster Vaccine Examples
Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Examples
Figure 8. Others Examples
Figure 9. Global Vaccines for the Elderly Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Vaccines for the Elderly Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Public Health Agency Examples
Figure 14. Others Examples
Figure 15. Global Vaccines for the Elderly Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Vaccines for the Elderly Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Vaccines for the Elderly Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Vaccines for the Elderly Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Vaccines for the Elderly Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Vaccines for the Elderly Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Vaccines for the Elderly by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Vaccines for the Elderly Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Vaccines for the Elderly Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Vaccines for the Elderly Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Vaccines for the Elderly Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Vaccines for the Elderly Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Vaccines for the Elderly Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Vaccines for the Elderly Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Vaccines for the Elderly Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Vaccines for the Elderly Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Vaccines for the Elderly Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Vaccines for the Elderly Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Vaccines for the Elderly Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Vaccines for the Elderly Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Vaccines for the Elderly Consumption Value Market Share by Region (2019-2030)
Figure 57. China Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Vaccines for the Elderly Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Vaccines for the Elderly Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Vaccines for the Elderly Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Vaccines for the Elderly Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Vaccines for the Elderly Market Drivers
Figure 78. Vaccines for the Elderly Market Restraints
Figure 79. Vaccines for the Elderly Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Vaccines for the Elderly in 2023
Figure 82. Manufacturing Process Analysis of Vaccines for the Elderly
Figure 83. Vaccines for the Elderly Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Vaccines for the Elderly Picture
Figure 2. Global Vaccines for the Elderly Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Vaccines for the Elderly Consumption Value Market Share by Type in 2023
Figure 4. Flu Vaccine Examples
Figure 5. Respiratory Syncytial Virus (RSV) Vaccine Examples
Figure 6. Recombinant Herpes Zoster Vaccine Examples
Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Examples
Figure 8. Others Examples
Figure 9. Global Vaccines for the Elderly Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Vaccines for the Elderly Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Public Health Agency Examples
Figure 14. Others Examples
Figure 15. Global Vaccines for the Elderly Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Vaccines for the Elderly Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Vaccines for the Elderly Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Vaccines for the Elderly Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Vaccines for the Elderly Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Vaccines for the Elderly Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Vaccines for the Elderly by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Vaccines for the Elderly Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Vaccines for the Elderly Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Vaccines for the Elderly Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Vaccines for the Elderly Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Vaccines for the Elderly Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Vaccines for the Elderly Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Vaccines for the Elderly Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Vaccines for the Elderly Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Vaccines for the Elderly Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Vaccines for the Elderly Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Vaccines for the Elderly Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Vaccines for the Elderly Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Vaccines for the Elderly Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Vaccines for the Elderly Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Vaccines for the Elderly Consumption Value Market Share by Region (2019-2030)
Figure 57. China Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Vaccines for the Elderly Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Vaccines for the Elderly Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Vaccines for the Elderly Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Vaccines for the Elderly Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Vaccines for the Elderly Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Vaccines for the Elderly Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Vaccines for the Elderly Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Vaccines for the Elderly Market Drivers
Figure 78. Vaccines for the Elderly Market Restraints
Figure 79. Vaccines for the Elderly Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Vaccines for the Elderly in 2023
Figure 82. Manufacturing Process Analysis of Vaccines for the Elderly
Figure 83. Vaccines for the Elderly Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
